Trade Register

Leading Japanese Pharmaceutical Company, Shionogi, Officially Opens Doors of Its New European Headquarters in Amsterdam

Retrieved on: 
Wednesday, November 23, 2022

SHIONOGI B.V., the European subsidiary of SHIONOGI & Co., Ltd. (Head Office: Osaka, Japan; hereafter "Shionogi"), officially opened the doors to its new European Headquarters in Herengracht, Amsterdam, today, marking the next stage of growth for the Japanese pharmaceutical company.

Key Points: 
  • SHIONOGI B.V., the European subsidiary of SHIONOGI & Co., Ltd. (Head Office: Osaka, Japan; hereafter "Shionogi"), officially opened the doors to its new European Headquarters in Herengracht, Amsterdam, today, marking the next stage of growth for the Japanese pharmaceutical company.
  • European CEO, Huw Tippett said: The decision to open our new headquarters in Amsterdam was an easy one for the business.
  • Amsterdam is a great city with a thriving life science community across both biopharmaceuticals and medical technology.
  • The new office adds further strength to Shionogis European capabilities, as we continue on our ambitious growth journey.